Table 4.
Single center | Multicenter | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Subgroup | Number of studies | Number of patients | I2 (%) | Overall effect size | 95% CI of overall effect size | P | Number of studies | Number of patients | I2 (%) | Overall effect size | 95% CI of overall effect size | P |
Operating time (min) | 8 | 1448 | 75 | SMD=0.23 | [−0.01, 0.48] | 0.06 | 11 | 3054 | 23 | SMD=−0.03 | [−0.11, 0.06] | 0.56 |
Blood loss (ml) | 7 | 968 | 91 | SMD=−0.27 | [−0.75, 0.21] | 0.27 | 10 | 2944 | 71 | SMD=−0.3 | [−0.45, −0.16] | <0.01 |
Pringle applied | 4 | 1188 | 98 | OR=0.34 | [0.03, 3.68] | 0.38 | 12 | 3211 | 67 | OR=0.93 | [0.69, 1.24] | 0.61 |
Pringle duration (min) | 5 | 902 | 39 | SMD=−0.13 | [−0.32, 0.06] | 0.18 | 8 | 2062 | 90 | SMD=0.05 | [−0.25, 0.36] | 0.74 |
Hospital stay (days) | 7 | 1307 | 39 | SMD=−0.04 | [−0.19, 0.12] | 0.65 | 11 | 2612 | 47 | SMD=0.03 | [−0.09, 0.14] | 0.63 |
SMD/OR, standard mean difference/odds ratio; statistically significant results are shown in bold.